Capital International Investors Portfolio holdings
Capital International, established in 1968 as a division of the Los Angeles-based Capital Group, is a global investment management firm focused on delivering equity investment solutions for institutional and individual clients worldwide. Operating as part of one of the oldest and largest asset managers, founded in 1931, it leverages Capital Group’s signature research-driven, long-term investment philosophy, managing billions in assets through a multi-manager system that diversifies risk and enhances performance. Headquartered in Los Angeles with a presence across North America, Europe, and Asia, Capital International specializes in international and global equity strategies, often through mutual funds like those in the American Funds family. Known for its rigorous fundamental analysis and commitment to client outcomes, it plays a key role in Capital Group’s mission to provide consistent, superior returns in global markets.
Top Buys
| 1 |
GE Aerospace
GE
|
$2.87B |
| 2 |
Public Storage
PSA
|
$1.65B |
| 3 |
Alphabet (Google) Class C
GOOG
|
$1.56B |
| 4 |
Union Pacific
UNP
|
$1.33B |
| 5 |
Welltower
WELL
|
$796M |
Top Sells
| 1 |
Broadcom
AVGO
|
$1.69B |
| 2 |
CVS Health
CVS
|
$1.56B |
| 3 |
Chubb
CB
|
$1.01B |
| 4 |
ConocoPhillips
COP
|
$997M |
| 5 |
Meta Platforms (Facebook)
META
|
$872M |
Sector Composition
| 1 | Technology | 21.21% |
| 2 | Healthcare | 15.27% |
| 3 | Financials | 12.72% |
| 4 | Industrials | 11.62% |
| 5 | Communication Services | 10.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Chevron
CVX
$324B
| $3.11B | 0.8% | 19,051,100 -2,698,042 | -12% | -$440M |
|
|
SGEN
27
DELISTED
Seagen Inc. Common Stock
SGEN
| $3.01B | 0.77% | 14,846,613 -1,737,847 | -10% | -$352M |
|
28
CME Group
CME
$96B
| $2.94B | 0.76% | 15,332,468 +553,942 | +4% | +$106M |
|
29
Danaher
DHR
$147B
| $2.9B | 0.75% | 11,496,682 +2,069,406 | +22% | +$522M |
|
30
General Mills
GIS
$26.4B
| $2.87B | 0.74% | 33,535,450 +468,171 | +1% | +$40M |
|
|
31
Chubb
CB
$110B
| $2.77B | 0.71% | 14,279,340 -5,204,825 | -27% | -$1.01B |
|
32
Johnson & Johnson
JNJ
$427B
| $2.65B | 0.68% | 17,101,685 -467,969 | -3% | -$72.5M |
|
33
ASML
ASML
$292B
| $2.65B | 0.68% | 3,890,612 +118,590 | +3% | +$80.7M |
|
34
AstraZeneca
AZN
$248B
| $2.65B | 0.68% | 38,128,710 -2,669,638 | -7% | -$185M |
|
35
Carrier Global
CARR
$55.5B
| $2.59B | 0.67% | 56,606,998 -284 | -0% | -$13K |
|
36
Applied Materials
AMAT
$128B
| $2.55B | 0.65% | 20,722,173 +2,602,169 | +14% | +$320M |
|
37
Zoetis
ZTS
$69.3B
| $2.51B | 0.65% | 15,094,390 +2,443,388 | +19% | +$407M |
|
38
Charter Communications
CHTR
$36.3B
| $2.5B | 0.64% | 6,989,996 -515,843 | -7% | -$184M |
|
|
39
ConocoPhillips
COP
$124B
| $2.45B | 0.63% | 24,661,581 -10,047,291 | -29% | -$997M |
|
40
Crown Castle
CCI
$43.2B
| $2.39B | 0.61% | 17,842,933 +5,038 | +0% | +$674K |
|
41
KLA
KLAC
$115B
| $2.36B | 0.61% | 5,924,727 -224,180 | -4% | -$89.5M |
|
|
42
Union Pacific
UNP
$133B
| $2.35B | 0.6% | 11,662,708 +6,595,704 | +130% | +$1.33B |
|
43
Intel
INTC
$107B
| $2.3B | 0.59% | 70,314,125 +7,224,859 | +11% | +$236M |
|
44
Pfizer
PFE
$141B
| $2.28B | 0.59% | 56,002,935 -2,302,688 | -4% | -$93.9M |
|
45
Eli Lilly
LLY
$657B
| $2.24B | 0.58% | 6,537,911 +769,496 | +13% | +$264M |
|
46
Elevance Health
ELV
$71.8B
| $2.23B | 0.57% | 4,846,310 -636,068 | -12% | -$292M |
|
47
Constellation Energy
CEG
$96.2B
| $2.21B | 0.57% | 28,100,904 +3,980,879 | +17% | +$312M |
|
48
KKR & Co
KKR
$124B
| $2.2B | 0.57% | 41,872,775 +2,852,538 | +7% | +$150M |
|
49
Nike
NKE
$114B
| $2.2B | 0.57% | 17,932,026 +274,402 | +2% | +$33.6M |
|
50
Edwards Lifesciences
EW
$47.8B
| $2.13B | 0.55% | 25,759,106 +3,017,120 | +13% | +$250M |
|